Norman S. Abramson
University of Pittsburgh
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Norman S. Abramson.
Critical Care Medicine | 1995
Herbert J. Rogove; Peter Safar; Kim Sutton-Tyrrell; Norman S. Abramson
OBJECTIVE To assess survival after cardiac arrest and to determine whether age is an independent determinant of late mortality or poor neurologic outcome. DESIGN Analyses using results of Brain Resuscitation Clinical Trial I (1979 to 1984) and Brain Resuscitation Clinical Trial II (1984 to 1989), two randomized, double-blind studies of outcome following cardiac arrest. SETTING A multicenter study in 12 acute care hospitals in nine countries (Brain Resuscitation Clinical Trial I), and 24 hospitals in eight countries (Brain Resuscitation Clinical Trial II). PATIENTS A total of 774 patients who were initially comatose after successful resuscitation from cardiac arrest. The analyses include both in- and out-of-hospital cardiac arrests. RESULTS The 6-month mortality rate for the entire group was 81%. Mortality rate was 94% for the oldest group (> 80 yrs) compared with 68% for the youngest group (< or = 45 yrs) (p < .01). Other independent predictors of mortality were history of diabetes mellitus, inhospital arrests, arrest time of > 5 mins, history of congestive heart failure, a noncardiac cause of arrest, and cardiopulmonary resuscitation time of > 20 mins. Of the 774 patients, 27% recovered good neurologic function. There was no statistically significant difference in neurologic recovery rates by age. Multivariate analysis showed that independent predictors of good neurologic recovery were: no history of diabetes mellitus, a cardiac cause of arrest, short arrest time, and short cardiopulmonary resuscitation time. CONCLUSION Increasing age was a factor in postresuscitation mortality, but was not an independent predictor of poor neurologic outcome.
Critical Care Medicine | 1996
Kang H. Lee; Derek C. Angus; Norman S. Abramson
OBJECTIVES To review the various outcomes from cardiopulmonary resuscitation (CPR), the factors that influence these outcomes, the costs associated with CPR, and the application of cost-analyses to CPR. DATA SOURCES Data used to prepare this article were drawn from published articles and work in progress. STUDY SELECTION Articles were selected for their relevance to the subjects of CPR and cost-analysis by MEDLINE keyword search. DATA EXTRACTION The authors extracted all applicable data from the English literature. DATA SYNTHESIS Cost-analysis studies of CPR programs are limited by the high variation in resources consumed and attribution of cost to these resources. Furthermore, cost projections have not been adjusted to reflect patient-dependent variation in outcome. Variation in the patients underlying condition, presenting cardiac rhythm, time to provision of definitive CPR, and effective perfusion all influence final outcome and, consequently, influence the cost-effectiveness of CPR programs. Based on cost data from previous studies, preliminary estimates of the cost-effectiveness of CPR programs for all 6-month survivors of a large international multicenter collaborative trial are
Acta Anaesthesiologica Scandinavica | 2005
Gad Bar-Joseph; Norman S. Abramson; Sheryl F. Kelsey; T. Mashiach; M.T. Craig; Peter Safar
406,605.00 per life saved (range
Annals of Emergency Medicine | 1987
Robert Levine; Marc J Gorayeb; Peter Safar; Norman S. Abramson; William Stezoski; Sheryl F. Kelsey
344,314.00 to
Annals of Emergency Medicine | 1990
Norman S. Abramson; Peter Safar
966,759.00), and
Annals of Emergency Medicine | 1993
M. von Planta; Gad Bar-Joseph; L Wiklund; N.G. Bircher; J.L. Falk; Norman S. Abramson
225,892.00 per quality-adjusted-life-year (range
Annals of Emergency Medicine | 1992
Norman S. Abramson; Sheryl F. Kelsey; Peter Safar; Kim Sutton-Tyrrell
191,286.00 to
Annals of Emergency Medicine | 1988
Kim Sutton-Tyrrell; Norman S. Abramson; Peter Safar; Katherine M. Detre; Sheryl F. Kelsey; Joyce Monroe; Oscar Reinmuth; Arsene Mullie; Karol Vandevelde; Ulf Hedstrand; Erik Edgren; Harald Breivik; Sven E. Gisvold; Per Lund; Andreas Skulberg; Dag Tore Fodstad; T. Tammisto; Pertti Nikki; M. Salmenperä; Michael S. Jastremski; Bjørn Lind; Per Vaagenes; Marialuisa Bozza-Marrubini; Rinaldo Cantadore; Erga Cerchiari; Dennis Potter; James V. Snyder; Angel Canton; Bogdan Kaminski
537,088.00). CONCLUSIONS Reported outcome from CPR has varied from reasonable rates of good recovery, including return to full employment to 100% mortality. Appropriate CPR is encouraged, but continued widespread application appears extremely expensive.
American Journal of Emergency Medicine | 1994
Per Vaagenes; Arsene Mullie; Dag Tore Fodstad; Norman S. Abramson; Peter Safar
Background: The use of sodium bicarbonate (SB) in cardiopulmonary resuscitation (CPR) is controversial. This study analyzes the effects of SB use on CPR outcome in the Brain Resuscitation Clinical Trial III (BRCT III), which was a multicenter randomized trial comparing high‐dose to standard‐dose epinephrine during CPR. Sodium bicarbonate use in BRCT III was optional.
Resuscitation | 1982
Norman S. Abramson; Peter Safar; Katherine M. Detre; Sheryl F. Kelsey; Oscar Reinmuth; James V. Snyder
We studied a clinically realistic field-to-hospital scenario in dogs with four-minute ventricular fibrillation (VF) cardiac arrest followed by 30-minute standard external CPR basic life support (BLS). At the end of this 34-minute insult, cardiopulmonary bypass (CPB) was used for early defibrillation and assisted circulation for one hour (n = 10). Recovery was compared with that of control dogs (n = 10) in which standard CPR with advanced life support (ALS) for another 30 minutes was used for restoration of spontaneous circulation (ROSC). Both groups had hemodilution and heparinization; controlled blood pressure, blood gases, ventilation, and other parameters for 20 hours; and intensive care to 72 hours. During CPR-BLS of 30 minutes in both groups signs of cerebral viability returned. CPB achieved ROSC more successfully (ten of ten vs five of ten CPR-ALS controls) (P less than .02); and more rapidly, with less defibrillation energy (first countershock in eight of ten) and with less epinephrine (P less than .01). CPB improved 72-hour survival (seven of ten vs three of ten controls) (P less than .05). Between two and 24 hours, of those with ROSC, cardiac complications killed three of ten CPB dogs (after weaning), and two of five CPR-ALS dogs (NS). All seven CPB survivors to 72 hours were neurologically normal; of the three CPR-ALS survivors, one remained with severe neurologic deficit and two were neurologically normal (seven of ten CPB vs two of ten controls, P = .025). Starting CPR-BLS within four minutes of arrest can maintain cerebral viability.(ABSTRACT TRUNCATED AT 250 WORDS)